Company intelligence / Profile preview

Shandong Luoxin Pharmaceutical

Linyi, Shandong, Chinaluoxin.cn ↗
Ownership
Private
Development stage
Other
01

Overview

The company has multiple approved products in China and is actively developing new chemical entities and generics through partnerships with international firms. Notable recent clinical results include approvals for duodenal ulcer treatments and respiratory therapies; ongoing development in oncology with third-generation EGFR inhibitors for NSCLC

Therapeutic areas
GastroenterologyPulmonologyOncology
Modalities
Small moleculeSynthetic peptideChemical drugs
Industry
Biotech
02

Partnerships

Marinomed Biotech AG – exclusive rights to Budesolv® budesonide nasal spray in ChinaJW Holdings – exclusive license/distribution agreement for Winuf® TPN productAurobindo Pharma – joint venture on respiratory productsYuhan Corporation – co-development/license of YH25448 EGFR inhibitor for NSCLC

Beyond the preview

Go deeper on Shandong Luoxin Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shandong Luoxin Pharmaceutical.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call